Article Details

Celltrion wins sales approval for biosimilar Vegzelma in Japan - KED Global

Retrieved on: 2022-09-27 11:23:33

Tags for this article:

Click the tags to see associated articles and topics

Celltrion wins sales approval for biosimilar Vegzelma in Japan - KED Global. View article details on hiswai:

Excerpt

Celltrion has been a major player in Japan as its Herzuma, a biosimilar of the breast cancer medicine Roche's Herceptin, dominated the market with ...

Article found on: www.kedglobal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up